Donald Trump and his wife Melania at an election night watch event in West Palm Beach, FL (Lynne Sladky/AP Images)
November 6, 2024 07:22 AM ESTUpdated 07:39 AM
FDA+
Law

New Trump era could be a boon for bio­phar­ma M&A, deal­mak­ing

Zachary Brennan

Senior Editor

As for­mer Pres­i­dent Don­ald Trump re­turns to pow­er — the As­so­ci­at­ed Press pro­ject­ed his pres­i­den­tial vic­to­ry Wednes­day morn­ing — the bio­phar­ma in­dus­try may see the door open …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

When gen­er­a­tive AI meets the FDA: First dig­i­tal health ad­comm kicks off dis­cus­sion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times